13F-HR filed by EcoR1 Capital, LLC
EcoR1 Capital, LLC filed this 13F-HR for the quarter ended 2020-06-30, filed 2020-08-14, with 49 holding rows worth $1,354,085,000.
- Accession
- 0001567619-20-015276
- Filer
- CIK 1587114
- Filed
- 2020-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2020
A holdings report, 49 entries on the cover page, a total value of $1,354,085,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,354,085,000 with VALUE read as thousands by filing date, 13F file number 028-16764. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| XENCOR INC | 98401F105 | COMMON STOCK | 4,547,072 | $147,280,000 | thousands by filing date | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 9,426,640 | $98,603,000 | thousands by filing date | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 2,642,218 | $89,122,000 | thousands by filing date | |
| MORPHIC HLDG INC | 61775R105 | COM | 2,837,973 | $76,767,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 4,608,529 | $75,119,000 | thousands by filing date | |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 3,153,797 | $73,547,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 2,721,993 | $69,139,000 | thousands by filing date | |
| ANAPTYSBIO INC | 032724106 | COM | 3,075,014 | $68,696,000 | thousands by filing date | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 2,103,950 | $59,458,000 | thousands by filing date | |
| NEOLEUKIN THERAPEUTICS INC | 64049K104 | COM | 3,536,684 | $58,709,000 | thousands by filing date | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 1,810,000 | $44,779,000 | thousands by filing date | |
| AKOUOS INC | 00973J101 | COM | 1,975,984 | $44,460,000 | thousands by filing date | |
| GERON CORP | 374163103 | COM | 19,230,769 | $41,923,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 357,849 | $40,856,000 | thousands by filing date | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 519,119 | $40,605,000 | thousands by filing date | |
| SURFACE ONCOLOGY INC | 86877M209 | COM | 5,033,861 | $33,022,000 | thousands by filing date | |
| ATRECA INC | 04965G109 | COM | 1,489,185 | $31,690,000 | thousands by filing date | |
| APPLIED MOLECULAR TRANS INC | 03824M109 | COM | 1,150,000 | $28,911,000 | thousands by filing date | |
| CONSTELLATION PHARMACEUTICALS INC. | 210373106 | Common Stock | 837,885 | $25,178,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 619,855 | $21,267,000 | thousands by filing date | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 733,561 | $17,738,000 | thousands by filing date | |
| BRISTOL-MYERS SQUIBB CO | 110122157 | RIGHT 99/99/9999 | 4,748,300 | $16,999,000 | thousands by filing date | |
| CYCLERION THERAPEUTICS INC | 23255M105 | COM | 2,742,276 | $16,207,000 | thousands by filing date | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 882,353 | $16,138,000 | thousands by filing date | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 859,802 | $15,064,000 | thousands by filing date | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 1,828,492 | $14,189,000 | thousands by filing date | |
| CONSTELLATION PHARMACEUTICALS INC. | 210373106 | Common Stock | 400,000 | $12,020,000 | thousands by filing date | call |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 200,000 | $8,950,000 | thousands by filing date | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 220,216 | $8,260,000 | thousands by filing date | |
| GLYCOMIMETICS INC | 38000Q102 | COM | 1,889,000 | $7,103,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 135,413 | $6,563,000 | thousands by filing date | |
| EVELO BIOSCIENCES INC | 299734103 | COM | 1,250,000 | $6,125,000 | thousands by filing date | |
| PREVAIL THERAPEUTICS INC | 74140Y101 | COM | 367,218 | $5,472,000 | thousands by filing date | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 500,000 | $5,160,000 | thousands by filing date | call |
| EXICURE INC | 30205M101 | COM | 1,673,301 | $4,083,000 | thousands by filing date | |
| SAVARA INC | 805111101 | COM | 1,432,664 | $3,567,000 | thousands by filing date | |
| DIANTHUS THERAPEUTICS INC COM | 55910K108 | Stock | 450,000 | $3,380,000 | thousands by filing date | |
| LIFESCI ACQUISITION CORP | 53228P208 | UNIT 03/31/2025 | 300,000 | $3,300,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 1,531,312 | $2,481,000 | thousands by filing date | |
| ROYALTY PHARMA PLC | G7709Q104 | SHS CLASS A | 50,000 | $2,428,000 | thousands by filing date | |
| FIVE PRIME THERAPEUTICS INC. | 33830X104 | Common Stock | 379,945 | $2,318,000 | thousands by filing date | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 737,612 | $2,006,000 | thousands by filing date | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 50,000 | $1,551,000 | thousands by filing date | |
| INTERCEPT PHARMACEUTICALS IN | 45845P108 | COM | 25,300 | $1,212,000 | thousands by filing date | call |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 94,819 | $1,187,000 | thousands by filing date | |
| XOMA ROYALTY CORPORATION | 98419J206 | COMMON STOCK | 50,809 | $1,004,000 | thousands by filing date | |
| KALEIDO BIOSCIENCES INC | 483347100 | COM | 31,374 | $233,000 | thousands by filing date | |
| EQUILLIUM INC | 29446K106 | COM | 59,014 | $174,000 | thousands by filing date | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 1,300 | $42,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001567619-20-015276 | this filing | 2020-08-14 | acceptance time not in the bulk data set |